Latest News and Press Releases

NEW YORK, NY--(Marketwired - Feb 14, 2014) - Nuvilex, Inc.'s (OTCQB: NVLX) Dr. Mark L. Rabe has something in common with 18 members of Congress. All of them want marijuana reclassified from its...

NEW YORK, NY--(Marketwired - Feb 12, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that's focused on getting into late phase clinical trials for the treatment of advanced,...

NEW YORK, NY--(Marketwired - Feb 10, 2014) - If Nuvilex, Inc. (OTCQB: NVLX) can use the Cell-in-a-Box™ technology to develop marijuana-based treatments for cancer with the same success it has...

NEW YORK, NY--(Marketwired - Feb 5, 2014) - Nuvilex, Inc. (OTCQB: NVLX) entered the medical marijuana arena in 2013 as a biotech that would use its expertise to develop treatments for hard to treat...

NEW YORK, NY--(Marketwired - Jan 27, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has emerged as a biotechnology firm that will develop treatments for both Cancer and Diabetes using the Cell-in-a-Box™...

NEW YORK, NY--(Marketwired - Jan 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) executives had to perk up when they heard the news coming from The New Yorker magazine's interview with President Obama...

NEW YORK, NY--(Marketwired - Jan 16, 2014) - Nuvilex, Inc. (OTCQB: NVLX) and a host of marijuana companies are keeping a close eye on what is happening with a petition drive in Florida to get the...

NEW YORK, NY--(Marketwired - Jan 14, 2014) - While Nuvilex, Inc. (OTCQB: NVLX) continues to lay the foundation for its medical marijuana subsidiary, Medical Marijuana Sciences, Inc. (MMS), a growing...

NEW YORK, NY--(Marketwired - Jan 9, 2014) - There aren't too many biotechnology companies in the marijuana space, but there's one that aims to be the leader among those in the industry. Nuvilex,...

NEW YORK, NY--(Marketwired - Jan 7, 2014) - This week executives at Nuvilex, Inc. (OTCQB: NVLX) expect New York state to join 20 other states and the District of Columbia in allowing the use of...